Development of Novel Therapeutic Approaches for NF1 Deficient Peripheral Nerve Sheath Tumors

Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Development of Novel Therapeutic Approaches for NF1 Deficient Peripheral Nerve Sheath Tumors

Published Date

2023

Publisher

Type

Thesis or Dissertation

Abstract

Malignant Peripheral Nerve Sheath Tumors (MPNSTs) associated with Neurofibromatosis Type 1 (NF1) pose a significant clinical challenge due to their aggressive nature and limited treatment options. This thesis endeavors to address this challenge by developing innovative therapeutic approaches for NF1-deficient PNSTs. The first objective of this research focused on the development of oncolytic adenovirus therapy specifically tailored for MPNSTs. Through the utilization of conditionally replicating adenoviruses (CRAds), we aimed to elucidate their cytotoxic and anti-tumor properties against MPNSTs. Our findings revealed that these adenoviruses exhibit a remarkable affinity for MPNST cells, leading to preferential replication and cell death compared to non-tumor control cells. Moreover, intratumoral injection of CRAds in murine models resulted in improved survival rates. In immunocompetent murine models, an increased intratumoral CD8+ T cell infiltrate was observed, promising a potential immunotherapeutic dimension to this approach. These results collectively underscore the feasibility of oncolytic virotherapy development as a novel strategy for combating MPNSTs. The second key objective of this study involved the identification of synthetic lethal targets specific to MPNSTs through a genome-wide CRISPR/Cas9 synthetic lethal screen. Our screening process unveiled a multitude of potential synthetic lethal interactors in the context of NF1-null and NF1/SUZ12-null Schwann cells and MPNST cells. Furthermore, the initial validation of these candidate interactors yielded promising results, substantiating the need for additional development and investigation. These findings hold significant promise for the use of genetic screens to identify and develop novel therapeutic interventions targeting MPNSTs.

Description

University of Minnesota Ph.D. dissertation.--- 2023. Major: Microbiology, Immunology and Cancer Biology. Advisor: David Largaespada. 1 computer file (PDF); viii, 183 pages.

Related to

Replaces

License

Collections

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Suggested citation

Nikrad, Julia. (2023). Development of Novel Therapeutic Approaches for NF1 Deficient Peripheral Nerve Sheath Tumors. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/259624.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.